Form 4: Bio-Path Holdings Director Douglas P. Morris Acquires Options

Director Douglas P. Morris acquired options to purchase 3,537 shares of Bio-Path Holdings common stock on July 30, 2024.

Summary

• On July 30, 2024, Douglas P. Morris, a director of Bio-Path Holdings, Inc., acquired options to purchase 3,537 shares of the company's common stock.
• The exercise price of these options is $1.55 per share.
• The options vest over a four-year period, starting with one-fourth vesting on the first anniversary of the grant date, July 30, 2024, and the remainder vesting in equal monthly increments thereafter.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The sentiment is neither positive nor negative as it simply reports a transaction.

Positives

• The acquisition of options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC when insiders, such as directors and officers, transact in their company's stock. These filings provide transparency to the market regarding insider activity.

Stakeholder Impact

• Shareholders may view the option grant as a sign of confidence from the director in the company's future performance.

Key Dates

Keywords

Bio-Path Holdings, Director, Options, Form 4, Acquisition, Morris, BPTH, Vesting